Literature DB >> 11135065

The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease.

D J Lager1, Q Qian, R J Bengal, M Ishibashi, V E Torres.   

Abstract

BACKGROUND: The pck rat is a recently identified model of polycystic kidney disease (PKD) and liver disease (PLD) that developed spontaneously in the rat strain Crj:CD/SD. Its pattern of inheritance is autosomal recessive.
METHODS: To characterize this new model, we studied pck rats derived from F9 breeding pairs from Charles River Japan and control Sprague-Dawley rats. Blood and tissues (kidneys, liver, and pancreas), obtained from these rats at 1, 7, 21, 70, and 182 days of age, were used for biochemical determinations, light and electron microscopy, and immunohistochemistry.
RESULTS: The pck rats develop progressive cystic enlargement of the kidneys after the first week of age, and liver cysts are evident by day 1. The renal cysts developed as a focal process from thick ascending loops of Henle, distal tubules, and collecting ducts in the corticomedullary region and outer medulla. Flat and polypoid epithelial hyperplasia were common in dilated tubules and cysts. Apoptosis was common and affected normal, as well as dilated tubules, but less frequently cysts lined by flat epithelium. The basement membranes of the cyst walls exhibited a variety of alterations, including thinning, lamellation, and thickening. Focal interstitial fibrosis and inflammation were evident by 70 days of age. Segmental glomerulosclerosis and segmental thickening of the basement membrane with associated effacement of the podocyte foot processes were noted in some rats at 70 days of age. The PKD was more severe in male than in female pck rats, as reflected by the higher kidney weights, while there was no gender difference in the severity of the PLD. Mild bile duct dilation was present as early as one day of age. With age, it became more severe, and the livers became markedly enlarged. Even then, however, there was only a mild increase in portal fibrosis, without formation of fibrous septae. Slight elevations of plasma blood urea nitrogen levels were detected at 70 and 182 days of age.
CONCLUSIONS: The pck rat is a new inherited model of PKD and PLD with a natural history and renal and hepatic histologic abnormalities that resemble human autosomal dominant PKD. This model may be useful for studying the pathogenesis and evaluating the potential therapies for PKD and PLD. The identification of the pck gene may provide further insight into the pathogenesis of autosomal dominant PKD.

Entities:  

Mesh:

Year:  2001        PMID: 11135065     DOI: 10.1046/j.1523-1755.2001.00473.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  72 in total

1.  Role of genetic modifiers in an orthologous rat model of ARPKD.

Authors:  Caitlin C O'Meara; Matthew Hoffman; William E Sweeney; Shirng-Wern Tsaih; Bing Xiao; Howard J Jacob; Ellis D Avner; Carol Moreno
Journal:  Physiol Genomics       Date:  2012-06-05       Impact factor: 3.107

2.  2-Hydroxyestradiol slows progression of experimental polycystic kidney disease.

Authors:  Sharon Anderson; Terry T Oyama; Jessie N Lindsley; William E Schutzer; Douglas R Beard; Vincent H Gattone; Radko Komers
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

3.  Altered Hepatobiliary Disposition of Tolvaptan and Selected Tolvaptan Metabolites in a Rodent Model of Polycystic Kidney Disease.

Authors:  James J Beaudoin; Jacqueline Bezençon; Yanguang Cao; Katsuhiko Mizuno; Sharin E Roth; William J Brock; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2018-11-30       Impact factor: 3.922

4.  Synergistic Genetic Interactions between Pkhd1 and Pkd1 Result in an ARPKD-Like Phenotype in Murine Models.

Authors:  Rory J Olson; Katharina Hopp; Harrison Wells; Jessica M Smith; Jessica Furtado; Megan M Constans; Diana L Escobar; Aron M Geurts; Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2019-08-19       Impact factor: 10.121

Review 5.  Regulation of transport in the connecting tubule and cortical collecting duct.

Authors:  Alexander Staruschenko
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

6.  Insignificant effect of secretin in rodent models of polycystic kidney and liver disease.

Authors:  Xiaofang Wang; Hong Ye; Christopher J Ward; Jessica Y S Chu; Tatyana V Masyuk; Nicholas F Larusso; Peter C Harris; Billy K C Chow; Vicente E Torres
Journal:  Am J Physiol Renal Physiol       Date:  2012-07-18

7.  Effect of a Vasopressin V2 Receptor Antagonist on Polycystic Kidney Disease Development in a Rat Model.

Authors:  Xiaofang Wang; Megan M Constans; Fouad T Chebib; Vicente E Torres; Lorenzo Pellegrini
Journal:  Am J Nephrol       Date:  2019-05-22       Impact factor: 3.754

8.  Src inhibition ameliorates polycystic kidney disease.

Authors:  William E Sweeney; Rodo O von Vigier; Philip Frost; Ellis D Avner
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

9.  Biliary and pancreatic dysgenesis in mice harboring a mutation in Pkhd1.

Authors:  Anna-Rachel Gallagher; Ernie L Esquivel; Tiffany S Briere; Xin Tian; Michihiro Mitobe; Luis F Menezes; Glen S Markowitz; Dhanpat Jain; Luiz F Onuchic; Stefan Somlo
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

10.  Pioglitazone Attenuates Cystic Burden in the PCK Rodent Model of Polycystic Kidney Disease.

Authors:  Bonnie L Blazer-Yost; Julie Haydon; Tracy Eggleston-Gulyas; Jey-Hsin Chen; Xiaofang Wang; Vincent Gattone; Vicente E Torres
Journal:  PPAR Res       Date:  2010-11-01       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.